Design and synthesis of novel thiazolidine-2,4-diones as hypoglycemic agents

Thiazolidinediones are well known for causing reduction in blood glucose levels. A number of thiazolidinediones have been approved for clinical use in diabetes. Present research work is based on the synthesis of thiazolidinedione derivatives that were designed previously using 2D QSAR for antidiabet...

Full description

Bibliographic Details
Main Authors: Prasanna A. Datar, Sainath B. Aher
Format: Article
Language:English
Published: Elsevier 2016-09-01
Series:Journal of Saudi Chemical Society
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319610312001615